Skip to content

Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation

Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04058548
Enrollment
27
Registered
2019-08-15
Start date
2019-09-05
Completion date
2021-05-12
Last updated
2021-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis

Keywords

cystic fibrosis, walk test

Brief summary

The aim of this study is to assess whether the 1 minute Sit to Stand (STS) test can be used as a measure of submaximal endurance during a pulmonary exacerbation of Cystic Fibrosis (CF) for patients in the acute care setting. We hypothesize that if the STS test is a valid measure of submaximal cardiovascular endurance, it will moderately correlate with 6 minute walk distance (6MWD).

Interventions

DIAGNOSTIC_TESTSit to stand test

Participants will complete a sit to stand test in addition to a 6 minute walk test

Sponsors

Boston Children's Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* patients age 6-35 with cystic fibrosis who are admitted for a pulmonary exacerbation and receive ongoing physical therapy throughout their admission.

Exclusion criteria

* patients with cystic fibrosis who are under the age of 6, * patients with cystic fibrosis who are not admitted for a pulmonary exacerbation, * patients with cystic fibrosis who are not being followed regularly by physical therapy (\>5x/week) throughout their inpatient admission, * patients with cystic fibrosis who are unable to follow instructions for standardized testing, * patients with cystic fibrosis who are not medically stable to participate in submaximal exercise testing. * patients whose inpatient admission is anticipated to be \<1 week. * Patients who are readmitted to the hospital within the year will not be included in the study more than once.

Design outcomes

Primary

MeasureTime frameDescription
6MWT power6 minutestotal distance in feet multiplied by bodyweight in pounds
1-minute STS repetitions:1 minuteNumber of STS completed
1 minute STS power:1 minutenumber of STS completed in 1 minute multiplied by bodyweight in pounds
6 Minute Walk Distance (6MWD):6 minutestotal distance in feet completed during test

Secondary

MeasureTime frameDescription
Heart rate1 minutebeats per minute
Oxygen saturation1-6 minutespercentage via pulse oximetry
Respiratory rate1-6 minbreaths per minute
Rating of perceived exertion6 minutesrating via Borg scale for perceived exertion: 0-10 with 0 being no breathlessness and 10 being maximal breathlessness

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026